Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Non-Current Assets (2020 - 2025)

Biofrontera has reported Non-Current Assets over the past 6 years, most recently at $10.5 million for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 648.11% year-over-year to $10.5 million; the TTM value through Dec 2025 reached $14.1 million, up 22.22%, while the annual FY2025 figure was $10.5 million, 648.11% up from the prior year.
  • Non-Current Assets for Q4 2025 was $10.5 million at Biofrontera, up from $1.0 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $10.5 million in Q4 2025 and troughed at $1.0 million in Q3 2025.
  • A 5-year average of $4.7 million and a median of $4.7 million in 2023 define the central range for Non-Current Assets.
  • On a YoY basis, Non-Current Assets climbed as much as 648.11% in 2025 and fell as far as 71.58% in 2025.
  • Year by year, Non-Current Assets stood at $6.8 million in 2021, then grew by 13.92% to $7.7 million in 2022, then crashed by 37.28% to $4.9 million in 2023, then plummeted by 71.16% to $1.4 million in 2024, then soared by 648.11% to $10.5 million in 2025.
  • Business Quant data shows Non-Current Assets for BFRI at $10.5 million in Q4 2025, $1.0 million in Q3 2025, and $1.3 million in Q2 2025.